|
ENTX Entera Bio Ltd 1638097 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-3,505,000.00 |
| Balance Sheet |
|
Current Assets
|
$12,493,000.00 |
|
Assets
|
$13,129,000.00 |
|
Current Liabilities
|
$1,576,000.00 |
|
Liabilities
|
$2,442,000.00 |
|
Equity
|
$10,687,000.00 |
|
Shares Out
|
46622239.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-3,090,000.00 |
| Market Analysis |
Market Cap
|
$137,535,605.05 |
|
Price
|
$2.78 |
|
BVPS
|
0.23 |
|
PB
|
12.83 |
|
EPS
|
0.07 |
|
FCF
|
$-3,090,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:39 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:38 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ENTX documents filed with the SEC.
ENTX Filings
Clear
